- Home
- HRTX vs TBN Comparison
HRTX vs TBN Comparison
Compare HRTX & TBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- TBN
- Stock Information
- Founded
- HRTX 1983
- TBN 2009
- Country
- HRTX United States
- TBN Australia
- Employees
- HRTX 126
- TBN N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- TBN
- Sector
- HRTX Health Care
- TBN
- Exchange
- HRTX Nasdaq
- TBN NYSE
- Market Cap
- HRTX 240.3M
- TBN 239.3M
- IPO Year
- HRTX 1987
- TBN 2024
- Fundamental
- Price
- HRTX $1.59
- TBN $16.15
- Analyst Decision
- HRTX Strong Buy
- TBN Buy
- Analyst Count
- HRTX 3
- TBN 3
- Target Price
- HRTX $5.67
- TBN $34.67
- AVG Volume (30 Days)
- HRTX 6.2M
- TBN 12.8K
- Earning Date
- HRTX 11-12-2024
- TBN 01-11-2025
- Dividend Yield
- HRTX N/A
- TBN N/A
- EPS Growth
- HRTX N/A
- TBN N/A
- EPS
- HRTX N/A
- TBN N/A
- Revenue
- HRTX $137,737,000.00
- TBN N/A
- Revenue This Year
- HRTX $13.10
- TBN N/A
- Revenue Next Year
- HRTX $18.76
- TBN N/A
- P/E Ratio
- HRTX N/A
- TBN N/A
- Revenue Growth
- HRTX 12.13
- TBN N/A
- 52 Week Low
- HRTX $1.04
- TBN $15.75
- 52 Week High
- HRTX $3.93
- TBN $25.99
- Technical
- Relative Strength Index (RSI)
- HRTX 50.28
- TBN N/A
- Support Level
- HRTX $1.53
- TBN N/A
- Resistance Level
- HRTX $1.88
- TBN N/A
- Average True Range (ATR)
- HRTX 0.17
- TBN 0.00
- MACD
- HRTX 0.01
- TBN 0.00
- Stochastic Oscillator
- HRTX 47.67
- TBN 0.00
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About TBN TAMBORAN RESOURCES CORPORATION
Tamboran Resources Corp is a gas company focused on supporting the Net Zero CO2 energy transition in Australia and Asia-Pacific through developing low CO2 unconventional gas resources in the Australian Northern Territory.